MAPT and nervous system disorder: While further investigation is needed to determine the contribution of miR-132 upregulation to Tau downregulation and neuroprotection, cardiac glycosides emerge as promising therapeutics for neurological disorders, if they can be improved to reduce systemic toxicity and enhance brain penetrance and retention.